GO
Loading...

CVS Caremark Corp

More

  • *McKesson says fails to get 75 pct threshold. FRANKFURT, Jan 13- U.S. drugs wholesaler group McKesson said on Monday it had failed to win enough support for a $8.4 billion offer to buy German distributor Celesio, leaving it empty-handed in a sector where cross-border consolidation is accelerating.

  • My top 10 stocks for 2014: Farr Tuesday, 31 Dec 2013 | 8:42 AM ET

    What 10 stocks does trader Michael Farr think are going to deliver in 2014? Click ahead to find out.

  • Dec 20- CVS Caremark Corp said on Friday that the Centers for Medicare and Medicaid Services lifted sanctions it had imposed earlier this year on a CVS Medicare drug plan aimed at seniors, allowing the company to resume enrolling members in 2014..

  • Rite Aid cuts full-year profit forecast; shares fall Thursday, 19 Dec 2013 | 12:29 PM ET

    Dec 19- Rite Aid Corp, the third-largest U.S. drugstore chain, cut its full-year profit forecast, mainly due to Medicare reimbursement cuts and higher cost of some generic drugs, sending the company's shares down as much as 11 percent. Rite Aid cut its full-year profit forecast to 17- 23 cents per share from 18- 27 cents per share.

  • *Ford, Jabil Circuit both tumble on outlook. NEW YORK, Dec 18- U.S. stocks rose in volatile trading on Wednesday after the Federal Reserve announced plans to trim its stimulus program, though it said its key interest rate would stay lower for even longer than previously promised.

  • UPDATE 2-CVS expects 2014 sales gain despite Obamacare Wednesday, 18 Dec 2013 | 12:50 PM ET

    NEW YORK, Dec 18- CVS Caremark Corp said on Wednesday that it expected sales and earnings to rise in 2014 despite only a "modest" benefit next year from the launch of Obamacare and a ban preventing it from marketing to some Medicare patients.

  • NEW YORK, Dec 18- U.S. stocks were little changed on Wednesday as the market cautiously awaited Federal Reserve's last policy announcement of the year which might determine the immediate future of its current program to stimulate the economy.

  • Midday movers: Ford, General Mills, FedEx & More Wednesday, 18 Dec 2013 | 12:36 PM ET

    Some of Wednesday's midday movers:

  • NEW YORK, Dec 18- U.S. stocks were little changed on Wednesday ahead of the Federal Reserve's last policy announcement of the year, which might determine the immediate future of its current program to stimulate the economy. Fed Chairman Ben Bernanke will follow the announcement with his final news conference at the helm of the U.S. central bank about 2:30 p.m..

  • US STOCKS-Wall Street ticks up, Fed decision awaited Wednesday, 18 Dec 2013 | 10:26 AM ET

    *FedEx results miss Wall Street estimates, shares dip. *Lennar shares up after results; Jabil slides on outlook. Fed Chairman Ben Bernanke will follow the 2:00 p.m. EST announcement with his final press conference at the helm of the U.S. central bank at 2:30 p.m..

  • Dec 18- CVS Caremark Corp said on Wednesday that it expected sales and earnings to rise in 2014 even though it anticipated only a "modest" benefit next year from the launch of the U.S.

  • CVS expects 2014 earnings to rise, lifts dividend Wednesday, 18 Dec 2013 | 7:39 AM ET

    Dec 18- CVS Caremark Corp said on Wednesday that it expected adjusted earnings to rise to a range of $4.36 to $4.50 per share in 2014.. The drugstore operator and pharmacy benefits manager said its board had approved a 22 percent increase in the quarterly dividend, bringing it up to 27.5 cents per share. The board also approved a new $6 billion share buyback program.

  • *Cardinal Health, CVS rise after JV announcement. *Rambus rallies after settling with Micron. There's no reason to think this is anything different than that, "said Paul Zemsky, head of asset allocation at ING Investment Management in New York.

  • Midday movers: Starbucks, Twitter, PVH & More Tuesday, 10 Dec 2013 | 1:23 PM ET

    Some of Tuesday's midday movers:

  • Dec 10- Pharmacy chain CVS Caremark Corp and pharmaceutical distributor Cardinal Health Inc on Tuesday announced a 10- year agreement to form the largest generic drug sourcing operation in the United States, the world's biggest generic drug market.

  • Dec 10- Pharmacy chain CVS Caremark Corp and pharmaceutical distributor Cardinal Health Inc said on Tuesday they would form the largest U.S. generic drug sourcing operation in a 10- year agreement to serve the world's biggest market for generic drugs. The 50-50 joint venture will be operational as soon as July 1, 2014.

  • Cramer: ‘I’m throwing up my hands with this group’ Wednesday, 4 Dec 2013 | 11:16 AM ET

    Muddled by inconsistent earnings and stock performances, one sector appears tougher and tougher to predict, CNBC's Jim Cramer says.

  • Early movers: KKD, POT, AAPL, TSLA & more Tuesday, 3 Dec 2013 | 7:50 AM ET

    Some of the names on the move ahead of the open.

  • The Nasdaq got a boost from the technology sector, with Apple up 1.9 percent at $556.07, Microsoft Corp up 1.4 percent at $38.13 and Amazon Inc up 1.8 percent at $393.62. We wouldn't be shocked at all to see the small and mid-cap names lag a little bit, "said Ryan Detrick, senior technical strategist with Schaeffer's Investment Research, in Cincinnati.

  • US STOCKS-Wall St gains in brief post-holiday session Friday, 29 Nov 2013 | 12:05 PM ET

    *Markets closing at 1 p.m.; volume expected to be light. NEW YORK, Nov 29- U.S. stocks rose modestly on Friday, with investors wary of making big bets in a short post-holiday session, though the S&P 500 is set for its longest weekly winning streak in 10 years.

Most Popular Video

Wednesday, 16 Apr 2014 | 10:41 AM ET

CNBC's Dominic Chu digs into the year-to-date S&P performance of the airlines and explains why it has been the lone bright spot for the industrial sector.

Wednesday, 16 Apr 2014 | 4:03 PM ET

Providing instant analysis to Google's quarterly numbers, with Victor Anthony, Topeka Capital Markets; Andrew Stoltmann of Stoltmann Law Offices; CNBC contributor Michael Yoshikami; "Fast Money" trader Tim Seymour; CNBC's Michelle Caruso-Cabrera and Dominic Chu.

Wednesday, 16 Apr 2014 | 12:35 PM ET

Intel CEO Brian Krzanich discusses some signs of stability in enterprise in the mature markets, and whether the emerging markets area steadying as well.